Claret Medical presentations at TVT 2016 on June 17th in Chicago:
- The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results: Dr. Nicolas M. Van Mieghem (Rotterdam, The Netherlands), 10:00 am
- The Sentinel US Pivotal Clinical Trial Design: Dr. Susheel Kodali (New York, USA), 10:10 am
The Sentinel CPS has received the CE Mark and is commercially available in Europe. It is limited to investigational use in the United States.